Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 3
1979 1
1980 13
1981 34
1982 39
1983 45
1984 64
1985 155
1986 298
1987 353
1988 491
1989 634
1990 709
1991 912
1992 891
1993 1104
1994 1133
1995 1189
1996 1276
1997 1320
1998 1381
1999 1404
2000 1360
2001 1386
2002 1348
2003 1386
2004 1401
2005 1553
2006 1472
2007 1488
2008 1554
2009 1499
2010 1479
2011 1449
2012 1348
2013 1367
2014 1340
2015 1252
2016 1136
2017 1096
2018 1020
2019 956
2020 949
2021 850
2022 843
2023 722
2024 198

Text availability

Article attribute

Article type

Publication date

Search Results

40,536 results

Results by year

Filters applied: . Clear all
Page 1
Growth Hormone and Insulin-Like Growth Factor-1.
Nicholls AR, Holt RI. Nicholls AR, et al. Front Horm Res. 2016;47:101-14. doi: 10.1159/000445173. Epub 2016 Jun 27. Front Horm Res. 2016. PMID: 27347885 Review.
Drug delivery of Insulin-like growth factor I.
Schultz I, Wurzel J, Meinel L. Schultz I, et al. Eur J Pharm Biopharm. 2015 Nov;97(Pt B):329-37. doi: 10.1016/j.ejpb.2015.04.026. Epub 2015 May 1. Eur J Pharm Biopharm. 2015. PMID: 25936856 Review.
This review starts off outlining the control of Insulin-like growth factor I (IGF-I) kinetics in Nature and by virtue of a complex system of 6 binding proteins controlling half-life and tissue distribution of this strong anabolic peptide. ...
This review starts off outlining the control of Insulin-like growth factor I (IGF-I) kinetics in Nature a …
Insulin-like growth factor-I and the liver.
Bonefeld K, Møller S. Bonefeld K, et al. Liver Int. 2011 Aug;31(7):911-9. doi: 10.1111/j.1478-3231.2010.02428.x. Epub 2011 Jan 24. Liver Int. 2011. PMID: 21733081 Review.
Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.
Guha N, Cowan DA, Sönksen PH, Holt RI. Guha N, et al. Anal Bioanal Chem. 2013 Dec;405(30):9669-83. doi: 10.1007/s00216-013-7229-y. Epub 2013 Aug 11. Anal Bioanal Chem. 2013. PMID: 23934394 Review.
To athletes, insulin-like growth factor-I (IGF-I) is an attractive performance-enhancing drug, particularly as an alternative to growth hormone (GH) because IGF-I mediates many of the anabolic actions of GH. ...
To athletes, insulin-like growth factor-I (IGF-I) is an attractive performance-enhancing drug, particular …
Human conditions of insulin-like growth factor-I (IGF-I) deficiency.
Puche JE, Castilla-Cortázar I. Puche JE, et al. J Transl Med. 2012 Nov 14;10:224. doi: 10.1186/1479-5876-10-224. J Transl Med. 2012. PMID: 23148873 Free PMC article. Review.
Insulin-like growth factor I (IGF-I) is a polypeptide hormone produced mainly by the liver in response to the endocrine GH stimulus, but it is also secreted by multiple tissues for autocrine/paracrine purposes. ...
Insulin-like growth factor I (IGF-I) is a polypeptide hormone produced mainly by the liver in response to …
Insulin-like growth factor-I in growth and metabolism.
Backeljauw P, Bang P, Dunger DB, Juul A, Le Bouc Y, Rosenfeld R. Backeljauw P, et al. J Pediatr Endocrinol Metab. 2010 Jan-Feb;23(1-2):3-16. doi: 10.1515/jpem.2010.23.1-2.3. J Pediatr Endocrinol Metab. 2010. PMID: 20432800 Review.
Deficiency of insulin-like growth factor-I (IGF-I) results in growth failure. A variety of molecular defects have been found to underlie severe primary IGF-I deficiency (IGFD), in which serum IGF-I concentrations are substantially decreased and …
Deficiency of insulin-like growth factor-I (IGF-I) results in growth failure. A variety of molecular defe …
Role of insulin-like growth factor I signaling in neurodegenerative diseases.
Trejo JL, Carro E, Garcia-Galloway E, Torres-Aleman I. Trejo JL, et al. J Mol Med (Berl). 2004 Mar;82(3):156-62. doi: 10.1007/s00109-003-0499-7. Epub 2003 Nov 28. J Mol Med (Berl). 2004. PMID: 14647921 Review.
Recent evidence indicates that intracellular trophic signaling may be compromised in several neurodegenerative diseases. Changes in the levels of insulin-like growth factor I (IGF-I), a trophic hormone with multiple neuroprotective actions, have …
Recent evidence indicates that intracellular trophic signaling may be compromised in several neurodegenerative diseases. Changes in the leve …
Insulin-like growth factor-I (lGF-l): safety and efficacy.
Laron Z. Laron Z. Pediatr Endocrinol Rev. 2004 Nov;2 Suppl 1:78-85. Pediatr Endocrinol Rev. 2004. PMID: 16456486 Review.
Insulin-like growth factor I (IGF-I) is a peptide synthesized mainly in the liver by stimulation by pituitary growth hormone (GH). ...
Insulin-like growth factor I (IGF-I) is a peptide synthesized mainly in the liver by stimulation by pitui …
40,536 results
You have reached the last available page of results. Please see the User Guide for more information.